3 Spectacular High-Yield Dividend Stocks to Buy in November
Not all dividend stocks are in the same league. Some offer puny yields. Others, though, provide exceptionally high ones plus solid long-term growth prospects.
Three Motley Fool contributors think they've identified stocks that belong squarely in the latter group. Here's why they view drugmakers (NYSE: ABBV), Novartis (NYSE: NVS), and Pfizer (NYSE: PFE) as spectacular high-yield dividend stocks to buy in November.
Keith Speights (AbbVie): You might wonder whether "spectacular" is an adjective that should be used with AbbVie after a brief glance at its third-quarter results. The big drugmaker's revenue fell 6% year over year to $13.9 billion. Its adjusted earnings per share sank 19.4% to $2.95. Overall, 2023 hasn't been a great year for the company with its share price down more than 10%.
Source Fool.com
AbbVie Inc. Aktie
Klare Kaufempfehlung: AbbVie Inc. erhält nur Buy-Einschätzungen.
Das Kursziel von 180 € für AbbVie Inc. impliziert eine leichte Steigerung gegenüber dem aktuellen Kurs von 169.8 €.
